Sign inGet started

Product

Solutions

Data

Developers

Pricing

Best GLP-1 Therapies Newsletters in 2026

NewsletterFIT tracks 4 newsletters that cover GLP-1 therapies as a primary topic, all with posts in the last 90 days. By publicly shown subscriber count, the largest are The FDA Group's Insider Newsletter (8K), Best Case Scenario (6K) and drjenbradley (2K).

Updated Nov 13, 2026 · sorted by publicly shown subscribers · methodology

  1. 1
    The FDA Group's Insider Newsletter8K subscribers

    SubstackSeveral times a week · last post 13 days ago

    From recent posts: The FDA Group's Insider Newsletter publishes biweekly regulatory updates, compliance case studies, and expert interviews for life science professionals navigating FDA guidance, quality audits, and therapeutic approvals…

    Likely audience: Regulatory affairs professionals

  2. 2
    Best Case Scenario6K subscribers

    SubstackSeveral times a week · last post 10 days ago

    From recent posts: The author reflects on the Her Longevity summit in New York, discussing the growing public awareness of experimental peptides and GLP-1 therapies among healthcare providers and fitness clubs. The piece highlights the sh…

    Likely audience: healthcare providers

  3. 3
    drjenbradley2K subscribers

    SubstackDaily · last post 10 days ago

    For women on GLP-1 medications making sense of everything the medication changed besides the scale: the food noise, the emotions, the relationships, the self you're becoming.

    Likely audience: women on GLP-1 therapy

  4. 4
    thelongevityloungewithholly—

    SubstackSeveral times a week · last post 5 days ago

    From recent posts: The author announces a move to Substack for better email delivery and shares personal updates about their mother's health and relocation. The content also features a health discussion on visceral fat and GLP-1 therapies…

    Likely audience: Women in midlife

Latest posts from these newsletters

Browse all topics